A common blood test for ovarian cancer is more likely to fall short for Black and Native American women, according to a new ...
A significant study detailing OncoSeek®'s efficacy was published in eClinicalMedicine, a clinical journal of The Lancet, titled A panel o ...
Mexico's premier center for regenerative medicine, anti-aging therapies, and advanced diagnostics, is proud to announce our collaboration with OncoInv - a global leader in multi-cancer early detection ...
Endometriosis affects roughly 10 percent (190 million) of reproductive age women and girls globally. According to the World ...
“How I Knew I Had Ovarian Cancer”: A Patient’s Story Reveals an Unexpected Benefit of Daily Exercise
A woman's story of literal strength shows how ovarian cancer can be missed—and the lighthearted recovery milestone every care ...
Health and Me on MSN4d
Ovarian Cancer Test May Be Less Effective For Black And Native American PatientsOvarian cancer is the fifth leading cause of cancer-related deaths among women in the U.S. However, the racial bias makes it ...
Evaluation of nemvaleukin for platinum-resistant ovarian cancer will be terminated based on OS data from an interim analysis ...
The Associated Press on MSN6d
Blood test for ovarian cancer misses some Black and Native American patients, study findsA common blood test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study finds. It's the latest example of medical tests that ...
Visit us on Facebook. Opens in a new tab or window Visit us on X. Opens in a new tab or window Visit us on Instagram. Opens in a new tab or window Visit us on LinkedIn. Opens in a new tab or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results